全文获取类型
收费全文 | 22887篇 |
免费 | 1949篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 174篇 |
儿科学 | 803篇 |
妇产科学 | 584篇 |
基础医学 | 3626篇 |
口腔科学 | 337篇 |
临床医学 | 2485篇 |
内科学 | 4302篇 |
皮肤病学 | 316篇 |
神经病学 | 2328篇 |
特种医学 | 408篇 |
外国民族医学 | 5篇 |
外科学 | 2613篇 |
综合类 | 200篇 |
一般理论 | 73篇 |
预防医学 | 3106篇 |
眼科学 | 371篇 |
药学 | 1512篇 |
1篇 | |
中国医学 | 39篇 |
肿瘤学 | 1600篇 |
出版年
2023年 | 297篇 |
2022年 | 500篇 |
2021年 | 960篇 |
2020年 | 584篇 |
2019年 | 812篇 |
2018年 | 949篇 |
2017年 | 685篇 |
2016年 | 694篇 |
2015年 | 751篇 |
2014年 | 992篇 |
2013年 | 1287篇 |
2012年 | 1793篇 |
2011年 | 1819篇 |
2010年 | 939篇 |
2009年 | 777篇 |
2008年 | 1326篇 |
2007年 | 1413篇 |
2006年 | 1172篇 |
2005年 | 1123篇 |
2004年 | 1032篇 |
2003年 | 929篇 |
2002年 | 732篇 |
2001年 | 242篇 |
2000年 | 246篇 |
1999年 | 238篇 |
1998年 | 180篇 |
1997年 | 144篇 |
1996年 | 96篇 |
1995年 | 110篇 |
1994年 | 85篇 |
1993年 | 78篇 |
1992年 | 153篇 |
1991年 | 150篇 |
1990年 | 130篇 |
1989年 | 135篇 |
1988年 | 88篇 |
1987年 | 112篇 |
1986年 | 116篇 |
1985年 | 102篇 |
1984年 | 70篇 |
1983年 | 63篇 |
1982年 | 47篇 |
1981年 | 51篇 |
1980年 | 44篇 |
1979年 | 63篇 |
1977年 | 46篇 |
1975年 | 47篇 |
1974年 | 54篇 |
1972年 | 48篇 |
1971年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
Rachel Anderson Lynell Clancy Neil Flynn Alex Kral Ricky Bluthenthal 《The International journal on drug policy》2003,14(5-6):461
An important operational aspect of Syringe Exchange Programmes (SEPs) is the venue of service delivery. This report describes the programmatic features of the Sacramento Area Needle Exchange (SANE), an illegal SEP operating in California, USA. SANE utilises “satellite exchangers” to distribute the bulk of its syringes and HIV risk reduction supplies. Advantages of relying primarily on Designated Exchangers (DE) for delivery of SEP services are that it: (1) allows for coverage of a large geographical area; (2) keeps operational cost low; (3) provides syringes to clients who may not want to or cannot use fixed site programmes; (4) limits the possibility of detection of programme personnel and clients by law enforcement. Limitations are that: (1) it is not as conducive as fixed sites to providing a wide range of ancillary services; (2) it may not be optimal for drug users who do not want to be reliant on other people for access to syringes; (3) those who receive services from a satellite exchanger may not derive as much counselling and referral services as direct exchangers. The lack of legal status, political support and adequate funding threatens the programme’s existence. 相似文献
65.
66.
67.
Rachel Hillier 《British medical journal》2003,326(7397):1022
68.
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. 总被引:1,自引:0,他引:1 下载免费PDF全文
S Todo J J Fung T E Starzl A Tzakis H Doyle K Abu-Elmagd A Jain R Selby O Bronsther W Marsh et al. 《Annals of surgery》1994,220(3):297-309
OBJECTIVE: The efficacy for primary orthotopic liver transplantation of a new immunosuppressive agent, FK 506 (tacrolimus, Prograf, Fujisawa USA, Deerfield, IL), was determined. SUMMARY BACKGROUND DATA: After 3 years of preclinical research, a clinical trial of FK 506 for orthotopic liver transplantation was begun in February 1989, first as a rescue therapy for patients with intractable rejection with conventional immunosuppression, then as a primary drug. METHODS: Between August 1989 and December 1993, 1391 recipients (1188 adult and 203 pediatric) of primary liver allografts were treated with FK 506 from the outset. Results from these patients were analyzed and compared with those of 1212 historical control patients (971 adult and 241 pediatric) given cyclosporine-based immunosuppression. RESULTS: Actuarial survival at 4 years was 86.2% with FK 506 versus 65.5% with cyclosporine in the pediatric patients (p < 0.0000) and 71.4% versus 65.5% in the adults (p < 0.0005). The need for retransplantation was reduced significantly for FK 506 patients. Four-year graft survival was 77.0% with FK 506 versus 48.4% with cyclosporine in the pediatric patients (p < 0.0000), and 61.9% with FK 506 versus 51.4% with cyclosporine in the adult recipients (p < 0.0000). Regression analysis revealed that reduction in mortality or graft loss from uncontrollable rejection, sepsis, technical failure, and recurrent original liver disease were responsible for the improved results with FK 506 therapy. CONCLUSIONS: FK 506 is a potent and superior immunosuppressive agent for orthotopic liver transplantation. 相似文献
69.
M V Beheshti D F Denny M G Glickman W Bodden J C Marsh R Strair T S Ravikumar 《Journal of vascular and interventional radiology : JVIR》1992,3(3):453-458
Chemotherapy for primary or metastatic hepatic malignancy is limited by poor tumor response and dose-related systemic toxicity. As an alternative to chemotherapy infusion by vein or by the hepatic artery, the authors have developed a percutaneous technique of isolated liver perfusion that allows the regional delivery of high-dose chemotherapy to the liver with little systemic toxicity. After placement of a hepatic artery infusion catheter, an 18-F double-balloon catheter is placed into the inferior vena cava through the opposite femoral vein. Balloons are inflated above and below the hepatic veins, thus isolating hepatic venous outflow. The effluent passes through fenestrations in the catheter and is pumped through charcoal hemoperfusion filters where the drug is removed. The filtered blood is returned to the patient through the internal jugular vein. Fifteen treatments have been conducted in eight patients in a phase I dose-escalation study with use of 5-fluorouracil (5-FU). While it is premature to assess tumor response to isolated liver perfusion, the data demonstrate that the procedure is safe and is tolerated by patients. Pharmacokinetic studies show a 5-FU extraction of up to 85%, with minimal drug leakage into the systemic circulation. This technique shows potential for improving liver tumor response while decreasing systemic toxicity. 相似文献
70.